Pdt Partners, LLC Blueprint Medicines Corp Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pdt Partners, LLC holds 15,129 shares of BPMC stock, worth $1.63 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

15,129

Previous 19,527 22.52%

Holding current value

$1.63 Million

Previous $1.8 Million 20.32%

% of portfolio

0.14%

Previous 0.21%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $321,801 - $438,876	-4,398 Reduced 22.52%	15,129 $1.44 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $160,058 - $338,030	-3,641 Reduced 15.72%	19,527 $1.8 Million
Q3 2023 Nov 14, 2023	SELL	$46.9 - $66.0 $1,219 - $1,716	-26 Reduced 0.11%	23,168 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $379 - $597	9 Added 0.04%	23,194 $1.47 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $225,276 - $296,650	-5,933 Reduced 20.38%	23,185 $1.04 Million

Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $458,640 - $742,581	11,170 Added 62.24%	29,118 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $896,143 - $1.39 Million	17,948 New	17,948 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $175,221 - $271,761	-3,874 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $209,583 - $426,449	3,874 New	3,874 $247,000
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $3.81 Million - $4.65 Million	-46,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $808,951 - $965,641	-8,918 Reduced 16.24%	46,000 $4.47 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $882,310 - $1.19 Million	-9,582 Reduced 14.86%	54,918 $6.16 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $301,084 - $420,023	-4,531 Reduced 6.56%	64,500 $5.98 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $1.52 Million - $2.11 Million	-26,596 Reduced 27.81%	69,031 $5.38 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $1.67 Million - $2.85 Million	34,627 Added 56.77%	95,627 $5.59 Million
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $220,209 - $272,547	3,300 Added 5.72%	61,000 $4.89 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $2,916 - $4,056	40 Added 0.07%	57,700 $4.24 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $4.24 Million - $5.64 Million	57,660 New	57,660 $5.44 Million

Others Institutions Holding BPMC

# of Institutions

313

Shares Held

60.6M

Call Options Held

634K

Put Options Held

691K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.44B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account